MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.87
-0.88 (-6.90%)
At close: Jun 5, 2026, 4:00 PM EDT
11.40
-0.47 (-3.96%)
After-hours: Jun 5, 2026, 7:53 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $59.14 million as of June 5, 2026. Its market cap has increased by 92.69% in one year.
Market Cap
59.14M
Enterprise Value
50.95M
1-Year Change
92.69%
Ranking
Category
Stock Price
$11.87
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $59.14M, a decrease of -84.69%. That is a compound annual growth rate of -33.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 59.14M | 12.98% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 67.63M |
| TScan Therapeutics | 66.66M |
| Acrivon Therapeutics | 66.34M |
| Seres Therapeutics | 66.33M |
| MediciNova | 64.97M |
| ImageneBio | 64.18M |
| Cingulate | 63.72M |
| PMV Pharmaceuticals | 63.46M |